FERG.UK

16,620

-1.07%↓

MNKS

1,494

+0.4%↑

FERG.UK

16,620

-1.07%↓

MNKS

1,494

+0.4%↑

FERG.UK

16,620

-1.07%↓

MNKS

1,494

+0.4%↑

FERG.UK

16,620

-1.07%↓

MNKS

1,494

+0.4%↑

FERG.UK

16,620

-1.07%↓

MNKS

1,494

+0.4%↑

Search

Derwent London PLC

Atidarymo kaina

SektoriusFinansų sektorius

1,730 0.82

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1721

Max

1732

Pagrindiniai rodikliai

By Trading Economics

Pajamos

95M

Pardavimai

141M

P/E

Sektoriaus vid.

8.128

25.743

Pelnas, tenkantis vienai akcijai

0.522

Dividendų pajamingumas

4.78

Pelno marža

66.974

Darbuotojai

201

EBITDA

80M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+24.16% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

4.78%

3.67%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.9B

Ankstesnė atidarymo kaina

1729.18

Ankstesnė uždarymo kaina

1730

Naujienos nuotaikos

By Acuity

67%

33%

440 / 526 reitingas Finance

Derwent London PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-31 22:20; UTC

Pagrindinės rinkos jėgos

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

2025-12-31 17:31; UTC

Pagrindinės rinkos jėgos

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

2025-12-31 16:30; UTC

Pagrindinės rinkos jėgos

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

2025-12-31 15:19; UTC

Pagrindinės rinkos jėgos

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

2025-12-31 15:17; UTC

Pagrindinės rinkos jėgos

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

2025-12-31 14:37; UTC

Pagrindinės rinkos jėgos

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

2025-12-31 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-31 21:13; UTC

Įsigijimai, susijungimai, perėmimai

10 People to Watch in Wealth Management in 2026 -- Barrons.com

2025-12-31 20:40; UTC

Rinkos pokalbiai

Dollar Posting Its Worst Year Since 2017 -- Market Talk

2025-12-31 20:22; UTC

Rinkos pokalbiai

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

2025-12-31 19:50; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

2025-12-31 19:31; UTC

Rinkos pokalbiai

Precious Metals Cap Off Record Runs -- Market Talk

2025-12-31 18:50; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-12-31 18:50; UTC

Rinkos pokalbiai

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

2025-12-31 17:17; UTC

Rinkos pokalbiai

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

2025-12-31 17:16; UTC

Pagrindinės rinkos jėgos

OwlTing Climbs on Launch of $10M Stock-Buyback Program

2025-12-31 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-12-31 17:00; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

2025-12-31 15:57; UTC

Įsigijimai, susijungimai, perėmimai

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

2025-12-31 15:54; UTC

Rinkos pokalbiai

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

2025-12-31 15:02; UTC

Pagrindinės rinkos jėgos

Nike Shares Rise After CEO Hill Buys $1M of Shares

2025-12-31 14:40; UTC

Įsigijimai, susijungimai, perėmimai

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

2025-12-31 14:20; UTC

Rinkos pokalbiai

Crude Futures On Track to End the Year With Losses -- Market Talk

2025-12-31 13:46; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

2025-12-31 13:01; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

2025-12-31 11:10; UTC

Rinkos pokalbiai

Copper Remains in Touching Distance of Record Highs -- Market Talk

2025-12-31 10:46; UTC

Rinkos pokalbiai

Euro on Track For Strong Annual Performance -- Market Talk

2025-12-31 10:25; UTC

Rinkos pokalbiai

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

2025-12-31 10:23; UTC

Rinkos pokalbiai

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

2025-12-31 09:33; UTC

Rinkos pokalbiai

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Akcijų palyginimas

Kainos pokytis

Derwent London PLC Prognozė

Kainos tikslas

By TipRanks

24.16% į viršų

12 mėnesių prognozė

Vidutinis 2,159.2 GBX  24.16%

Aukščiausias 2,460 GBX

Žemiausias 2,000 GBX

Remiantis 7 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Derwent London PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

7 ratings

4

Pirkti

3

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

440 / 526 reitingas Finansų sektorius

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Derwent London PLC

Derwent London plc owns 63 buildings in a commercial real estate portfolio predominantly in central London valued at £4.8 billion as at 30 June 2024, making it the largest London office-focused real estate investment trust (REIT). Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing. We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1. As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, publishing its pathway to achieving this goal in July 2020. Our science-based carbon targets validated by the Science Based Targets initiative (SBTi). In 2013 the Company launched a voluntary Community Fund which has to date supported over 160 community projects in the West End and the Tech Belt. The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.
help-icon Live chat